Intestinal macrophages and response to microbial encroachment

Mucosal Immunology

Volumn 4, Issue 1, 2011, Pages 31-42

  Smith, P D ^a   Smythies, L E ^a   Shen, R ^a   Greenwell Wild, T ^b   Gliozzi, M ^b   Wahl, S M ^b  

^a University of Alabama at Birmingham   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CD14 ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 8; SMAD PROTEIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA;

CROHN DISEASE; CYTOKINE RELEASE; DIGESTIVE SYSTEM INFLAMMATION; GASTROINTESTINAL MUCOSA; HELICOBACTER INFECTION; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTESTINAL MACROPHAGE; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LAMINA PROPRIA; MACROPHAGE; MACROPHAGE MIGRATION; MONOCYTE; MUCOSAL IMMUNITY; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; VIRUS TRANSMISSION;

EID: 78650807608     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2010.66     Document Type: Review

References (133)

1. Lee, S. H., Starkey, P. M. & Gordon, S. Quantitative analysis of total macrophage content in adult mouse tissues: Immunochemical studies with monoclonal antibody F4/80. J. Exp. Med. 161, 475-489 (1985).
2. Smith, P. D., Smythies, L. E. & Wahl, S. M. Macrophage effector function. In Clinical Immunology. Vol 1 (Rich, R.R., Fleisher, T.A., Sherarer, W.T., Kotzin, B. & Schroeder, H.W.J., eds) 19.11-19.19 (Harcourt Health Sciences, London, 2001).
3. Hoffman, J. A., Kafatos, F. C., Janeway, C. A. Jr & Ezekowitz, R. A. B. Phylogenetic perspectives in innate immunity. Science 284, 1313-1318 (1999).
4. Round, J. L. & Mazmanian, S. K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313-323 (2009).
5. Malamud, D. & Wahl, S. M. The mouth: A gateway or a trap for HIV? AIDS 24, 5-16 (2010).
6. Ma, G. et al. Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J. Exp. Med. 200, 1337-1346 (2004).
7. Fukata, M., Vamadevan, A. S. & Abreu, M. T. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in infl ammatory disorders. Semin. Immunol. 21, 242-253 (2009).
8. Bortoluci, K. R. & Medzhitov, R. Control of infection by pyroptosis and autophagy: Role of TLR and NLR. Cell. Mol. Life Sci. 67, 1643-1651 (2010).
9. Miao, E. A. et al. Innate immune detection of the type III secretion apparatus through the NLRC4 infl ammasome. Proc. Natl. Acad. Sci. USA 107, 3076-3080 (2010).
10. Guo, P. et al. Dual nature of the adaptive immune system in lampreys. Nature 459, 796-801 (2009).
11. Fearon, D. T. & Locksley, R. M. The instructive role of innate immunity in the acquired immune response. Science 272, 50-54 (1996).
12. Roach, J. C. et al. The evolution of vertebrate Toll-like receptors. Proc. Natl. Acad. Sci. USA 102, 9577-9582 (2005).
13. Gordon, S., Clarke, S., Greaves, D. & Doyle, A. Molecular immunobiology of macrophages: Recent progress. Curr. Opin. Immunol. 7, 24-33 (1995).
14. Valledor, A. F., Borras, F. E., Cullell-Young, M. & Celada, A. Transcription factors that regulate monocyte/macrophage differentiation. J. Leukoc. Biol. 63, 405-417 (1998).
15. Fogg, D. K. et al. A clonogenic bone marrow progenitor specifi c for macrophages and dendritic cells. Science 311, 83-87 (2006).
16. McKercher, S. R. et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15, 5647-5658 (1996).
17. Nagamura-Inoue, T., Tamura, T. & Ozato, K. Transcription factors that regulate growth and differentiation of myeloid cells. Int. Rev. Immunol. 20, 83-105 (2001).
18. Voso, M. T. et al. Inhibition of hematopoiesis by competitive binding of transcription factor PU.1. Proc. Natl. Acad. Sci. USA 91, 7932-7936 (1994).
19. Jack, G. D., Zhang, L. & Friedman, A. D. M-CSF elevates c-Fos and phospho-C/EBPalpha(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specifi cation. Blood 114, 2172-2180 (2009).
20. Friedman, A. D. Transcriptional control of granulocyte and monocyte development. Oncogene 26, 6816-6828 (2007).
21. Dale, D. C., Boxer, L. & Liles, W. C. The phagocytes: Neutrophils and monocytes. Blood 112, 935-945 (2008).
22. Rees, A. J. Monocyte and macrophage biology: An overview. Semin. Nephrol. 30, 216-233 (2010).
23. Gordon, S. & Martinez, F. O. Alternative activation of macrophages: Mechanism and functions. Immunity 32, 593-604 (2010).
24. Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969 (2008).
25. Danese, S. & Mantovani, A. Infl ammatory bowel disease and intestinal cancer: A paradigm of the Yin-Yang interplay between infl ammation and cancer. Oncogene 29, 3313-3323 (2010).
26. Wendelsdorf, K., Bassaganya-Riera, J., Hontecillas, R. & Eubank, S. Model of colonic infl ammation: Immune modulatory mechanisms in infl ammatory bowel disease. J. Theor. Biol. 264, 1225-1239 (2010).
27. Moos, V. et al. Impaired immune functions of monocytes and macrophages in Whipple's disease. Gastroenterology 138, 210-220 (2010).
28. Smythies, L. E. et al. Mucosal IL-8 and TGF-β recruit blood monocytes: Evidence for cross-talk between the lamina propria stroma and myeloid cells. J. Leukoc. Biol. 80, 492-499 (2006).
29. Smythies, L. E. et al. Human intestinal macrophages display profound infl ammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 115, 66-75 (2005).
30. Blobe, G. C., Schiemann, W. P. & Lodish, H. F. Role of transforming growth factor β in human disease. N. Engl. J. Med. 342, 1350-1358 (2000).
31. Wahl, S. M., Hunt, D. A. & Wakefi eld, L. M. Transforming growth factor type β (TGF- β) induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84, 5788-5792 (1987).
32. Wahl, S. M. Transforming growth factor-beta: Innately bipolar. Curr. Opin. Immunol. 19, 55-62 (2007).
33. Burgio, V. T., Fais, S., Boirivant, M., Perrone, A. & Pallone, F. Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology 109, 1029-1038 (1995).
34. Inoue, T. et al. Blockade of PSGL-1 attenuates CD14 + monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice. J. Leukoc. Biol. 77, 287-295 (2005).
35. Grimm, M. C., Pavli, P. & Doe, W. F. Evidence for a CD14 + population of monocytes in infl ammatory bowel disease mucosa-implications for pathogenesis. Clin. Exp. Immunol. 100, 291-297 (1995).
36. Smith, P. D. et al. Isolation and purifi cation of CD14-negative mucosal macrophages from normal human small intestine. J. Immunol. Methods 202, 1-11 (1997).
37. Allison, M. C. & Poulter, L. W. Changes in phenotypically distinct mucosal macrophage populations may be a prerequisite for the development of infl ammatory bowel disease. Clin. Exp. Immunol. 85, 504-509 (1991).
38. Rugtveit, J., Brandtzaeg, P., Halstensen, T. S., Fausa, O. & Scott, H. Increased macrophage subset in infl ammatory bowel disease: Apparent recruitment from peripheral blood monocytes. Gut 35, 669-674 (1994).
39. Mahida, Y. R., Patel, S., Gionchetti, P., Vaux, D. & Jewell, D. P. Macrophage subpopulations in lamina propria of normal and infl amed colon and terminal ileum. Gut 30, 826-834 (1989).
40. Rugtveit, J., Bakka, A. & Brandtzaeg, P. Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human infl ammatory bowel disease (IBD). Clin. Exp. Immunol. 110, 104-113 (1997).
41. Rugtveit, J. et al. Respiratory burst of intestinal macrophages in infl ammatory bowel disease is mainly caused by CD14 + L1 + monocyte derived cells. Gut 37, 367-373 (1995).
42. Grimm, M. C. et al. Direct evidence of monocyte recruitment to infl ammatory bowel disease mucosa. J. Gastroenterol. Hepatol. 10, 387-395 (1995).
43. Kamada, N. et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J. Clin. Invest. 118, 2269-2280 (2008).
44. Hale-Donze, H. et al. Mycobacterium avium complex promotes recruitment of monocyte hosts for HIV-1 and bacteria. J. Immunol. 169, 3854-3862 (2002).
45. Orenstein, J. M., Fox, C. & Wahl, S. M. Macrophages as a source of HIV during opportunistic infections. Science 276, 1857-1861 (1997).
46. Vazquez, N., Greenwell-Wild, T., Rekka, S., Orenstein, J. M. & Wahl, S. M. Mycobacterium avium-induced SOCS contributes to resistance to IFN-gamma-mediated mycobactericidal activity in human macrophages. J. Leukoc. Biol. 80, 1136-1144 (2006).
47. Greenwell-Wild, T. et al. Mycobacterium avium infection and modulation of human macrophage gene expression. J. Immunol. 169, 6286-6297 (2002).
48. Smythies, L. E. et al. Infl ammation anergy in human intestinal macrophages is due to Smad-induced I β B β expression and NF- β B inactivation. J. Biol. Chem. 285, 19593-19604 (2010).
49. Nares, S. et al. Rapid myeloid cell transcriptional and proteomic responses to periodontopathogenic Porphyromonas gingivalis. Am. J. Pathol. 174, 1400-1414 (2009).
50. Areschoug, T. & Gordon, S. Scavenger receptors: Role in innate immunity and microbial pathogenesis. Cell Microbiol. 11, 1160-1169 (2009).
51. Schiffmann, E., Corcoran, B. A. & Wahl, S. M. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc. Natl. Acad. Sci. USA 72, 1059-1062 (1975).
52. Smith, P. D. et al. Monocyte function in the acquired immune defi ciency syndrome. Defective chemotaxis. J. Clin. Invest. 74, 2121-2128 (1984).
53. Smith, P. D. et al. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J. Immunol. 167, 2651-2656 (2001).
54. Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
55. Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001).
56. Hampe, J. et al. A genome-wide association scan of nonsynonymous SNPs identifi es a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211 (2007).
57. Rioux, J. D. et al. Genome-wide association study identifi es new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39, 596-604 (2007).
58. Parkes, M. et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 39, 830-832 (2007).
59. Consortium, W. T. C. C. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
60. Travassos, L. H. et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 11, 55-62 (2010).
61. Glasser, A. L. & Darfeuille-Michaud, A. Abnormalities in the handling of intracellular bacteria in Crohn's disease: A link between infectious etiology and host genetic susceptibility. Arch. Immunol. Ther. Exp. (Warsz) 56, 237-244 (2008).
62. Cadwell, K., Stappenbeck, T. S. & Virgin, H. W. Role of autophagy and autophagy genes in infl ammatory bowel disease. Curr. Top. Microbiol. Immunol. 335, 141-167 (2009).
63. Cadwell, K. et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141, 1135-1145 (2010).
64. van Beelen, A. J. et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27, 660-669 (2007).
65. Fujino, S. et al. Increased expression of interleukin 17 in infl ammatory bowel disease. Gut 52, 65-70 (2003).
66. Holtta, V. et al. IL-23/IL-17 immunity as a hallmark of Crohn's disease. Infl amm. Bowel. Dis. 14, 1175-1184 (2008).
67. Seiderer, J. et al. Role of the novel Th17 cytokine IL-17F in infl ammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Infl amm. Bowel. Dis. 14, 437-445 (2008).
68. McGovern, D. P. et al. Genetic epistasis of IL23/IL17 pathway genes in Crohn's disease. Infl amm. Bowel. Dis. 15, 883-889 (2009).
69. Darfeuille-Michaud, A. et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115, 1405-1413 (1998).
70. Martin, H. M. et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127, 80-93 (2004).
71. Lapaquette, P., Glasser, A. L., Huett, A., Xavier, R. J. & Darfeuille- Michaud, A. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol. 12, 99-113 (2010).
72. Chervonsky, A. V. Infl uence of microbial environment on autoimmunity. Nat. Immunol. 11, 28-35 (2010).
73. Wu, H. J. et al. Gut-residing segmented fi lamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815-827 (2010).
74. Denning, T. L., Wang, Y. C., Patel, S. R., Williams, I. R. & Pulendran, B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 8, 1086-1094 (2007).
75. Mangan, P. R. et al. Transforming growth factor- β induces development of the T(H)17 lineage. Nature 441, 231-234 (2006).
76. Kimura, A. & Kishimoto, T. IL-6: Regulator of Treg/Th17 balance. Eur. J. Immunol. 40, 1830-1835 (2010).
77. Katsifi s, G. E., Rekka, S., Moutsopoulos, N. M., Pillemer, S. & Wahl, S. M. Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis. Am. J. Pathol. 175, 1167-1177 (2009).
78. Smith, P. D., Saini, S. S., Raffeld, M., Manischewitz, J. F. & Wahl, S. M. Cytomegalovirus induction of tumor necrosis factor- β by human monocytes and mucosal macrophages. J. Clin. Invest. 90, 1642-1648 (1992).
79. Maheshwari, A. et al. Cytomegalovirus blocks intestinal stroma-induced down-regulation of macrophage HIV-1 infection. J. Leukoc. Biol. 80, 1111-1117 (2006).
80. Nathan, C. F. Secretory products of macrophages. J. Clin. Invest. 79, 319-326 (1987).
81. Schenk, M., Bouchon, A., Seibold, F. & Mueller, C. TREM-1-expressing intestinal macrophages crucially amplify chronic infl ammation in experimental colitis and infl ammatory bowel diseases. J. Clin. Invest. 117, 3097-3106 (2007).
82. Zheng, H. et al. MYD88-dependent and -independent activation of TREM-1 via specifi c TLR ligands. Eur. J. Immunol. 40, 162-171 (2010).
83. Ford, J. W. & McVicar, D. W. TREM and TREM-like receptors in infl ammation and disease. Curr. Opin. Immunol. 21, 38-46 (2009).
84. Bleharski, J. R. et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J. Immunol. 170, 3812-3818 (2003).
85. Schenk, M., Bouchon, A., Birrer, S., Colonna, M. & Mueller, C. Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine. J. Immunol. 174, 517-524 (2005).
86. Sharif, O. & Knapp, S. From expression to signaling: Roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 213, 701-713 (2008).
87. Naiki, Y. et al. Transforming growth factor- β differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide- induced TLR4 signaling. J. Biol. Chem. 280, 5491-5495 (2005).
88. Neurath, M. F. et al. Cytokine gene transcription by NF- β B family members in patients with infl ammatory bowel disease. Ann NY Acad. Sci. 859, 149-159 (1998).
89. Rogler, G. et al. Nuclear factor kappaB is activated in macrophages and epithelial cells of infl amed intestinal mucosa. Gastroenterology 115, 357-369 (1998).
90. Chen, W., Frank, M. E., Jin, W. & Wahl, S. M. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14, 715-725 (2001).
91. Fadok, V. A., Bratton, D. L. & Henson, P. M. Phagocyte receptors for apoptotic cells: Recognition, uptake, and consequences. J. Clin. Invest. 108, 957-962 (2001).
92. Fadok, V. A. et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinfl ammatory cytokines production through autocrine/ paracrine mechanisms involving TGF- ß, PGE2, and PAF. J. Clin. Invest. 101, 890-898 (1998).
93. Wahl, S. M., Wen, J. & Moutsopoulos, N. TGF-beta: A mobile purveyor of immune privilege. Immunol. Rev. 213, 213-227 (2006).
94. Chen, W. et al. Conversion of peripheral CD4 + CD25-naive T cells to CD4 + CD25 + regulatory T cells by TGF- β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
95. Qian, B. F. & Wahl, S. M. TGF-beta can leave you breathless. Curr. Opin. Pharmacol. 9, 454-461 (2009).
96. Curotto de Lafaille, M. A. & Lafaille, J. J. Natural and adaptive foxp3+ regulatory T cells: More of the same or a division of labor? Immunity 30, 626-635 (2009).
97. Saruta, M. et al. Characterization of FOXP3 + CD4 + regulatory T cells in Crohn's disease. Clin. Immunol. 125, 281-290 (2007).
98. Harris, P. R. et al. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 134, 491-499 (2008).
99. Manicassamy, S. et al. Activation of β -catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329, 849-853 (2010).
100. Shen, R., Smythies, L. E., Clements, R. H., Novak, L. & Smith, P. D. Dendritic cells transmit HIV-1 through human small intestinal mucosa. J. Leukoc. Biol. 87, 663-670 (2010).
101. Shen, R. et al. GP41-specifi c antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium. J. Immunol. 184, 3648-3655 (2010).
102. Meng, G. et al. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5 + cells. Nat. Med. 8, 150-156 (2002).
103. Alfsen, A., Yu, H., Magerus-Chatinet, A., Schmitt, A. & Bomsel, M. HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce effi cient HIV-1 transcytosis across epithelial cell monolayer. Mol. Biol. Cell 16, 4267-4279 (2005).
104. Shacklett, B. L. Immune responses to HIV and SIV in mucosal tissues: "location, location, location". Curr. Opin. HIV AIDS 5, 128-134 (2010).
105. Smit-McBride, Z., Mattapallil, J. J., McChesney, M., Ferrick, D. & Dandekar, S. Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4 + T-cell depletion at all stages of simian immunodefi ciency virus infection compared to peripheral lymphocytes. J. Virol. 72, 6646-6656 (1998).
106. Veazey, R. S. et al. Gastrointestinal tract as a major site of CD4 + T cell depletion and viral replication in SIV infection. Science 280, 427-431 (1998).
107. Guadalupe, M. et al. Severe CD4 + T cell depletion in gut lymphoid tissue during primary human immunodefi ciency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77, 11708-11717 (2003).
108. Brenchley, J. M. et al. T-cell subsets that harbor human immunodefi ciency virus (HIV) in vivo: Implications for HIV pathogenesis. J. Virol. 78, 1160-1168 (2004).
109. Mehandru, S. et al. Primary HIV-1 infection is associated with preferential depletion of CD4 + T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200, 761-770 (2004).
110. Li, Q. et al. Peak SIV replication in resting memory CD4 + T cells depletes gut lamina propria CD4 + T cells. Nature 434, 1148-1152 (2005).
111. Mattapallil, J. J. et al. Massive infection and loss of memory CD4 + T cells in multiple tissues during acute SIV infection. Nature 434, 1093-1097 (2005).
112. Mehandru, S. et al. Mechanisms of gastrointestinal CD4 + T-cell depletion during acute and early human immunodefi ciency virus type 1 infection. J. Virol. 81, 599-612 (2007).
113. Li, L., Meng, G., Graham, M. F., Shaw, G. M. & Smith, P. D. Intestinal macrophages display reduced permissiveness to human immunodefi ciency virus 1 and decreased surface CCR5. Gastroenterology 116, 1043-1053 (1999).
114. Meng, G. et al. Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodefi ciency virus type 1 in the intestinal mucosa. J. Infect. Dis. 182, 785-791 (2000).
115. Shen, R. et al. Macrophages in vaginal but not in intestinal mucosa are monocyte-like and permissive to HIV-1. J. Virol. 83, 3258-3267 (2009).
116. Kedzierska, K., Crowe, S. M., Turville, S. & Cunningham, A. L. The infl uence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev. Med. Virol. 13, 39-56 (2003).
117. Gorry, P. R., Churchill, M., Crowe, S. M., Cunningham, A. L. & Gabuzda, D. Pathogenesis of macrophage tropic HIV-1. Curr. HIV Res. 3, 53-60 (2005).
118. Carter, C. A. & Ehrlich, L. S. Cell biology of HIV-1 infection of macrophages. Annu. Rev. Microbiol. 62, 425-443 (2008).
119. Orenstein, J. M. & Wahl, S. M. The macrophage origin of the HIVexpressing multinucleated giant cells in hyperplastic tonsils and adenoids. Ultrastruct. Pathol. 23, 79-91 (1999).
120. Wahl, S. M. et al. Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune defi ciency syndrome. J. Exp. Med. 173, 981-991 (1991).
121. Moutsopoulos, N. M., Greenwell-Wild, T. & Wahl, S. M. Differential mucosal susceptibility in HIV-1 transmission and infection. Adv. Dent. Res. 19, 52-56 (2006).
122. Crowe, S. M. et al. The macrophage: The intersection between HIV infection and atherosclerosis. J. Leukoc. Biol. 87, 589-598 (2010).
123. Yadav, A. & Collman, R. G. CNS infl ammation and macrophage/ microglial biology associated with HIV-1 infection. J. Neuroimmune. Pharmacol. 4, 430-447 (2009).
124. Smith, P. D., Fox, C. H., Masur, H., Winter, H. S. & Alling, D. W. Quantitative analysis of mononuclear cells expressing human immunodefi ciency virus type 1 RNA in esophageal mucosa. J. Exp. Med. 180, 1541-1546 (1994).
125. Wahl, S. M., Greenwell-Wild, T. & Vazquez, N. HIV accomplices and adversaries in macrophage infection. J. Leukoc. Biol. 80, 973-983 (2006).
126. Wahl, S. M. et al. Viral and host cofactors facilitate HIV-1 replication in macrophages. J. Leukoc. Biol. 74, 726-735 (2003).
127. Vazquez, N. et al. Human immunodefi ciency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J. Virol. 79, 4479-4491 (2005).
128. Bergamaschi, A. & Pancino, G. Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 7, 31 (2010).
129. Peng, G. et al. Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110, 393-400 (2007).
130. Peng, G., Lei, K. J., Jin, W., Greenwell-Wild, T. & Wahl, S. M. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J. Exp. Med. 203, 41-46 (2006).
131. Sheehy, A. M., Gaddis, N. C., Choi, J. D. & Malim, M. H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650 (2002).
132. Zheng, Y. et al. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J. Immunol. 172, 2778-2784 (2004).
133. Hyytiäinen, M., Penttinen, C. & Keski-Oja, J. Latent TGF-beta binding proteins: Extracellular matrix association and roles in TGF-beta activation. Crit. Rev. Clin. Lab. Sci. 41, 233-264 (2004).